DOE OSTI · 1735077
Prostate cancer-associated secreted proteins
Abstract
Methods are provided for treating a subject with prostate cancer and/or diagnosing a subject at risk for prostate cancer, which can include measuring increased expression of at least two prostate cancer-related molecules in a sample obtained from a subject, including the prostate cancer-related molecules AGR2, AGR3, CRISP3, CCL3, CEACAM5, CEACAM6, IL24, MMP9, CXCL14, CD90, POSTN, and SFRP4. The methods can include administering at therapy to a subject with prostate cancer. Methods are provided for treating a subject with intermediate- or high-risk prostate cancer, which can include measuring increased expression of MMP9 in a sample obtained from a subject compared to a control representing expression of MMP9 expected in a sample from a subject who has low-risk prostate cancer.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Qian, Wei-Jun, Shi, Tujin, Liu, Alvin Y.. 2020-07-28. Prostate cancer-associated secreted proteins. https://www.osti.gov/biblio/1735077
Cite the original work for its findings. Save a collection to share your selection of sources.